Prognostic significance of stromelysin 3, gelatinase A, and urokinase expression in breast cancer

Human Pathology

Volumn 29, Issue 9, 1998, Pages 979-985

  Têtu, Bernard ^a,b   Brisson, Jacques ^a   Lapointe, Hélène ^a   Bernard, Pascale ^a  

^a UNIVERSITÉ LAVAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

Breast neoplasms; Gelatinase; Stromelysin; Urokinase

Indexed keywords

GELATINASE A; STROMELYSIN; UROKINASE;

ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER INVASION; ENZYME ACTIVATION; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MULTIVARIATE ANALYSIS; MYOFIBROBLAST; PROGNOSIS; STROMA CELL;

EID: 0031660713     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(98)90204-0     Document Type: Article

References (35)

1. Grégoire M, Lieubeau B: The role of fibroblasts in tumor behavior. Cancer Metastasis Rev 14:339-350, 1995
2. Roger P, Montcourrier P, Maudelonde T, et al: Cathepsin D immunostaining in paraffin-embedded breast cancer cells and macrophages: Correlation with cytosolic assay. HUM PATHOL 25:863-871, 1994
3. Gasparini G, Harris L: Clinical importance of the determination of tumor angiogenesis in breast carcinoma: Much more than a new prognostic tool. J Clin Oncol 13:765-782, 1995
4. Seemayer TA, Schürch W, Lagacé R, et al: Myofibroblasts in the stroma of invasive and metastatic carcinoma: A host response to neoplasia. Am J Surg Pathol 3:525-533, 1979
5. Zipori D: Stromal cells in tumor growth and regression. Cancer J 3:164-169, 1990
6. McDougall JR, Matrisian LM: Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis. Cancer Metastasis Rev 14:351-362, 1995
7. Basset P, Okada A, Chenard MP, et al: Matrix metalloproteinases as stromal effectors of human carcinoma progression: Therapeutic implications. Matrix Biol 15:535-541, 1997
8. Poulsom R, Pignatelli M, Stetler-Stevenson WG, et al: Stromal expression of 72 kda type IV collagenase (MMP-2) and TIMP-2 mRNAs in colorectal neoplasia. Am J Pathol 141:389-396, 1992
9. Rouyer N, Wolf C, Chenard MP, et al: Stromelysin-3 gene expression in human cancer: An overview. Invasion Metastasis 14:269-275, 1994-95
10. Wolf C, Rouyer N, Lutz Y, et al: Stromelysin 3 belongs to a subgroup of proteinases expressed in breast carcinoma fibroblastic cells and possibly implicated in tumor progression. Proc Natl Acad Sci U S A 90:1843-1847, 1993
11. Basset P, BellocqJP, Wolf C, et al: A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature 348:699-704, 1990
12. Pei D, Majmudar G, Weiss SJ: Hydrolytic inactivation of a breast carcinoma cell-derived serpin by human stromelysin-3. J Biol Chem 269:25849-25855, 1994
13. Engel G, Heselmeyer K, Auer G, et al: Correlation between stromelysin-3 mRNA level and outcome of human breast cancer. Int J Cancer 58:830-835, 1994
14. Chenard MP, O'Siorain L, Shering S, et al: High levels of stromelysin-3 correlate with poor prognosis in patients with breast carcinoma. Int J Cancer 69:448-451, 1996
15. Leone A, Correale M, Dragone CD, et al: Gelatinase A/MMMP-2 serum levels and neoplastic progression in breast cancer patients. Int J Oncol 4:551-554, 1994
16. Daidone MG, Silvestrini R, D'Errico A, et al: Laminin receptors, collagenase IV and prognosis in node-negative breast cancers. Int J Cancer 48:529-532, 1991
17. Visscher DW, Hoyhtya M, Ottosen SK, et al: Enhanced expression of tissue inhibitor of metalloproteinase-2 (TIMP-2) in the stroma of breast carcinomas correlates with tumor recurrence. Int J Cancer 59:339-344, 1994
18. Duffy MJ, Reilly D, McDermott E, et al: Urokinase plasminogen activator as a prognostic marker in different subgroups of patients with breast cancer. Cancer 74:2276-2280, 1994
19. Fisher ER, Sass R, Fisher B, collaborating NSABP investigators: Pathologic findings from the national surgical adjuvant project for breast cancers (Protocol No. 4). Cancer 53:712-723, 1984
20. Têtu B, Brisson J, Côté C, et al: Prognostic significance of cathepsin-D expression in node-positive breast carcinoma: An immunohistochemical study. Int J Cancer 55:429-435, 1993
21. Isola J, Weitz S, Visakorpi T, et al: Cathepsin-D expression detected by immunohistochemistry has independent prognostic value in axillary-node-negative breast cancer. J Clin Oncol 11:36-43, 1993
22. Nadji M, Fresno M, Nassiri M, et al: Cathepsin D in host stromal cells, but not in tumor cells, is associated with aggressive behavior in node-negative breast cancer. HUM PATHOL 27:890-895, 1996
23. Hsu S-M, Raine L, Fanger H: Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29:577-580, 1981
24. Dressler LG, Bartow SA: DNA flow cytometry in solid tumors: Practical aspects and clinical applications. Semin Diagn Pathol 6:55-82, 1989
25. Erdos T, Best-Belpomme M, Bessada R: A rapid assay for binding estradiol to uterine receptor(s). Anal Biochem 37:244-252, 1970
26. Noël AC, Polette M, Lewalle J-M, et al: Coordinate enhancement of gelatinase A mRNA and activity levels in human fibroblasts in response to breast-adenocarcinoma cells. Int J Cancer 56:331-336, 1994
27. Biswas C, Zhang Y, DeCastro R, et al: The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily. Cancer Res 55:434-439, 1995
28. Joensuu H, Toikkanen S, Isola J: Stromal cell cathepsin D expression and long-term survival in breast cancer. Br J Cancer 71:155-159, 1995
29. O'Donoghue AEMA, Poller DN, Bell JA, et al: Cathepsin D in primary breast carcinoma: Adverse prognosis is associated with expression of cathepsin D in stromal cells. Breast Cancer Res Treat 33:137-145, 1995
30. Hosthansen C, Johannessen B, Hoyerhansen G, et al: Urokinase-type plasminogen activation in three human breast cancer cell lines correlates with their in vitro invasiveness. Clin Exp Metastasis 14:297-307, 1996
31. Andreasen PA, Georg B, Lund LR, et al: Plasminogen activator inhibitors: Hormonally regulated serpins. Mol Cell Endocrinol 68:1-19, 1990
32. Noël A, Lefebvre O, Maquoi E, et al: Stromelysin-3 expression promotes tumor take in nude mice. J Clin Invest 97:1924-1930, 1996
33. Nagase H: Activation mechanisms of matrix metalloproteinases. Biol Chem 378:151-160, 1997
34. Lee KS, Rha SY, Kim SJ, et al: Sequential activation and production of matrix metalloproteinase-2 during breast cancer progression. Clin Exp Metastasis 14:512-519, 1996
35. Onisto M, Riccio MP, Scannapieco P, et al: Gelatinase A/TIMP-2 imbalance in lymph-node-positive breast carcinomas, as measured by RT-PCR. Int J Cancer 63:621-626, 1995